Canada markets closed

ImmunoPrecise Antibodies Ltd. (IPA.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
7.90-0.13 (-1.62%)
At close: 3:59PM EDT
Currency in CAD

Valuation Measures

Market Cap (intraday) 5150.72M
Enterprise Value 3140.01M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)8.77
Price/Book (mrq)4.19
Enterprise Value/Revenue 38.15
Enterprise Value/EBITDA 7-34.60

Trading Information

Stock Price History

Beta (5Y Monthly) -0.19
52-Week Change 3-9.78%
S&P500 52-Week Change 337.55%
52 Week High 326.25
52 Week Low 35.50
50-Day Moving Average 38.94
200-Day Moving Average 314.15

Share Statistics

Avg Vol (3 month) 333.14k
Avg Vol (10 day) 324.09k
Shares Outstanding 519.08M
Implied Shares Outstanding 6N/A
Float 17.07M
% Held by Insiders 16.75%
% Held by Institutions 17.23%
Shares Short (Jun. 14, 2021) 437.77k
Short Ratio (Jun. 14, 2021) 41.58
Short % of Float (Jun. 14, 2021) 4N/A
Short % of Shares Outstanding (Jun. 14, 2021) 40.20%
Shares Short (prior month May 13, 2021) 446.01k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 390,000.00
Trailing Annual Dividend Yield 31,120,797.07%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Nov. 22, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Nov. 22, 2020

Financial Highlights

Fiscal Year

Fiscal Year Ends Apr. 29, 2020
Most Recent Quarter (mrq)Jan. 30, 2021


Profit Margin -18.93%
Operating Margin (ttm)-31.16%

Management Effectiveness

Return on Assets (ttm)-9.67%
Return on Equity (ttm)-13.93%

Income Statement

Revenue (ttm)17.18M
Revenue Per Share (ttm)1.13
Quarterly Revenue Growth (yoy)11.90%
Gross Profit (ttm)7.95M
Net Income Avi to Common (ttm)-3.25M
Diluted EPS (ttm)-0.21
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)15.72M
Total Cash Per Share (mrq)0.82
Total Debt (mrq)3.67M
Total Debt/Equity (mrq)11.37
Current Ratio (mrq)3.39
Book Value Per Share (mrq)1.88

Cash Flow Statement

Operating Cash Flow (ttm)595.17k
Levered Free Cash Flow (ttm)776.89k